Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?
Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.
Iron in multiple sclerosis: roles in neurodegeneration and repair.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Protective Role of (RS )-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Management of pain in advanced disease.
The impact of the human genome project on complex disease.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Reproduction and the risk of multiple sclerosis.
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
Sphingolipids in neuroinflammation.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.

Pages